Summary
The product of the retinoblastoma tumor-suppressor gene (RB) is a ubiquitously expressed, 105-kDa nuclear phosphoprotein (pRB). The pRB protein negatively regulates the cellular G1/S phase transition, and it is at this point in the cell cycle that it is thought to play its role as a tumor suppressor. The growth-inhibitory effects of pRB are exerted, at least in part, through the E2F family of transcription factors. This chapter reviews the insights into the mechanism of action of the E2F family members that have been obtained through overexpression studies. Studies in RB-/- SAOS-2 cells have provided evidence in support of the hypothesis that the E2F family members are negatively regulated by pRB and the related protein p130. In particular, the results obtained are consistent with the earlier biochemical data which suggested that E2F1 is regulated primarily by pRB, and E2F4 by p130. Results relating to p107 are also discussed. Consistent with the proposed role of pRB and E2F1 as coregulators of entry into S phase, experiments have demonstrated that overexpression of E2F1 is sufficient to override the cell cycle arrests caused by serum deprivation of fibroblasts or transforming growth factor-β (TGFβ) treatment of mink lung epithelial cells. However, at least in the case of the serum deprivation induced arrest, the ultimate result of E2F1 overexpression is death by p53-dependent apoptosis. In light of this and other data, a model is discussed as to how functional inactivation of pRB and p53 might cooperate to promote tumorigenesis. A number of studies have demonstrated the oncogenic potential of E2F family members, at least under certain conditions. This is, again, in keeping with the notion that these proteins play a critical role in controlling cellular proliferation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bendata LR, Buck VM, Zamaian M, Johnston LH, La Thangue NB (1993) Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J 12: 4317–4324
Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J (1994) Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353–361
Beijhersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R (1994a) E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8: 2680–2690
Beijersbergen RL, Hijmans EM, Zhu L, Bernards R (1994b) Interaction of c-myc with the Rb related protein p107 results in inhibition of c-myc mediated transactivation. EMBO J 13: 4080–4086
Clarke AR, Maandag ER, van Roon M, van der Lugt NMT, van der Valk M, Hooper ML, Berns A, Riele H (1992) Requirement for a functional Rb-1 gene in murine development Nature 359: 328–330
Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA (1993) Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392–2404
Dalton S (1992) Cell cycle regulation of the human cdc2 gene. EMBO J 11: 1797–1804
Debbas M, White E (1993) Wild-type p53 mediates apoptosis by E1 A, which is inhibited by E1 B. Genes Dev 7: 546–554
Dynlacht BD, Flores O, Lees JA, Harlow E (1994) Differential regulation of E2F transactivation by cyclin/cdk complexes. Genes Dev 8: 1772–1786
Ewen ME (1994) The cell cycle and the retinoblastoma family. Cancer Metastaris Rev 13: 45–66
Ewen ME, Sluss HK, Whitehouse LL, Livingston DM (1993) TGFp1 inhibition of cdk4 synthesis is linked to cell cycle arrest Cell. 74: 1009–1020
Ewen ME, Oliver C, Sluss H, Miller S, Peeper D (1995) p53-Dependent repression of CDK4 translation in TFG-p-induced G, cell-cycle arrest. Genes Dev 9: 204–217
Flemingron EK, Speck SH, Kaelin WG (1993) E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 90: 6914–6918
Ginsberg D, Vairo G, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM (1994) E2F-4 a new member of the E2F transcription factor family, interacts with p107 Genes. Dev 8: 2665–2679
Girling R, Bandara LR, Ormondroyd E, Lam EW-F, Kotecha S, Mohun T, La Thangue NB (1994) Molecular characterisation of Xenopus laevis DP proteins. Mol Biol Cell 5: 1081–1092
Goodrich DW, Lee W-H (1992) Abrogation by c-myc of G, phase arrest induced RB protein but not by p53. Nature 360: 177–179
Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R (1994) Binding and suppression of the myc transcriptional activation domain by p107. Science 264: 251–254
Guan K-L, Jenkins CW, Li Y, Nichols MA, Wu X, O’Keefe CL, Matera AG, Xiong Y (1994) Growth suppression by p18, a p16 INK4/MTS1 and p14 INK4B/MTS1-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939–2952
Hamel PA, Gill RM, Phillips RA, Gallie BL (1992) Transcriptional repression of the E2-containing promoters EllaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol 12: 3431–3438
Hamel PA, Phillips RA, Muncaster M, Gallie BL (1993) Speculations on the role of RB1 in tissue specific differentiation, tumour initiation and tunour progression. FASEB J 7: 846–854
Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-p-induced cell cycle arrest. Nature 371: 257–261
Hannon GJ, Demetrick D, Beach D (1993) Isolation of the Rb-related p130 through its interactions with CDK2 and cyclins. Genes Dev 7: 2378–2391
Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A (1992) A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337–350
Helin K, Harlow E, Fattaey A (1993a) Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma gene. Mol Cell Biol 13: 6501–6508
Helin K, Wu C-L, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E (1993b) Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev 7: 1850–1861
Herber B, Truss M, Beato M, Muller R (1994) Inducible regulatory elements in the cyclin D1 promoter. Oncogene 9: 1295–1304
Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 6: 177–185
Hijmans EM, Voorhoeue PM, Beijersbergen RL, van’t Veer LJ, Bernards R (1995) E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 15: 3082–3089
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993–1006
Howe JA, Mymryk JS, Egan C, Branton PE, Bayley ST (1990) Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis. Proc Natl Acad Sci USA 87: 5883–5887
Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8: 1300–1310
Hsiao K-M, McMahon SL, Farnham P (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8: 1526–1537
Huang H-JS, Yee J-K, Shew J-Y, Chen P-L, Bookstein R, Friedmann T, Lee EY-HP, Lee W-H (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563–1566
Huber HE, Edwards G, Goodhart PJ, Patrick DR, Huang PS, Ivey-Noble M, Barnett SF, Oliff A, Heimbrook DC (1993) Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci USA 90: 3525–3529
Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC (1993) Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13: 7802–7812
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359: 295–300
Johnson D, Cress W, Jakoi L, Nevins J (1994a) Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci USA 91: 12823–12827
Johnson DG, Ohtani K, Nevins JR (1994b) Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8: 1514–1525
Johnson DG, Schwarz JK, Cress WD, Nevins JR (1993) Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349–352
Joliff K, Li Y, Johnson LF (1991) Multiple protein DNA interactions in the TATA less mouse thymidylate synthase promoter. Nucleic Acids Res 19: 2267–2274
Kaelin WG Jr, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK (1992) Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364
Kovesdi I, Reichel R, Nevins JR (1986) Identification of a cellular transcription factor involved in ElA trans-activation. Cell 45: 219–228
Krek W, Livingston DM, Shirodkar S (1993) Binding to DNA and retinoblastoma gene promoted by complex formation of different E2F family members. Science 262: 1557–1560
Krek W, Ewen M, Shirodkar S, Arany Z, Kaelin WG Jr, Livingston DM (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 1–20
La Thangue NB, Rigby PWJ (1987) An adenovirus ElA-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49: 507–513
Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J (1990) Growth inhibition by TGF-13 linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175–185
Lam EW-F, Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-Myb transcription. EMBO 12: 2705–2713
Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294
Lee EY-HP, Hu N, Yuan S-SF, Cox LA, Bradley A, Lee W-H, Herrup K (1994) Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev 8: 2008–2021
Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K (1993) The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13: 7813–7825
Li Y, Slansky JE, Myers DJ, Drinkwater NR, Kaelin WG, Farnham PJ (1993) Cloning chromosomal location and characterization of mouse E2F1. Mol Cell Biol 14: 1861–1869
Lowe SW, Ruley HE (1993) Stabilisation of the tumour suppressor p53 is induced by adenovirus El a and accompanies apoptosis. Genes Dev 7: 535–545
Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M, Bartek J (1994) DNA tumor virus oncoproteins and retinblastoma gene mutations share the ability to relieve the cell’s requirement for cyclin D1 function in G1. J Cell Biol 125: 625–638
Mittnacht S, Weinberg RA (1991) G,IS phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65: 381–393
Moran B, Zerler B (1988) Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene. Mol Cell Biol 8: 1756–1764
Moran E (1993) DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev 3: 63–70
Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994) p53 dependent apoptosis produced by Rb deficiency in the developing mouse lens. Nature 371: 72–74
Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. PNAS 91: 2945–2949
Mymryk JS, Shire K, Bayley ST (1994) Induction of apoptosis by adenovirus type Ela in rat cells requires a proliferation block. Oncogene 9: 1188–1193
Neuman E, Flemington EK, Sellers WR, Kaelin WG (1994) Transcription of the E2F1 gene is rendered cell-cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 14: 6607–6615
Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424–429
Oswald F, Lovec H, Moroy T, Lipp M (1994)E2F dependent regulation of human myc: transactivation by cyclins D1 and A overrides tumour supressor protein functions. Oncogene 9: 2029–2036
Pan H, Griep AE (1994) Altered cell cycle regulation in the lens HPV-16 or E7 transgenic mice: implications for tumour suppressor gene function in development. Genes Dev 8: 1285–1299
Pearson BE, Nasheuer HP, Wang TSF (1991) Human DNA polymerase a gene, sequences controlling expression in cycling and serum stimulated cells. Mol Cell Biol 11: 2081–2095
Peeper DS, Keblusek P, Helin K, Toebes M, Van der Eb AJ, Zantema A (1995) Phosphorylation of a specific site in E2F1 affects its electrophoretic mobility and promotes pRb binding in vitro. Oncogene 10: 39–48
Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M (1994) Repression of cyclin Dl: a novel function of MYC. Mol Cell Biol 14: 4032–4043
Polyaak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts J, Tempst P, Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66
Qian Y, Luckey C, Horton L, Esser M, Templeton DJ (1992) Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol Cell Biol 12: 5363–5372
Qin X-Q, Chittenden T, Livingston DM, Kaelin WG (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6: 953–964
Qin X-Q, Livingston DM, Kaelin WG, Adams P (1994) Deregulated E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91: 10918–10922
Qin X-Q, Livingston DM, Ewen M, Sellers WR, Arany Z, Kaelin WG (1995) The transcription factor E2F1 is a downstream target of RB action. Mol Biol Cell 15: 742–755
Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW (1994) Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 9: 405–415
Saenz Robles MT, Symonds H, Chen J, Van Dyke T (1994) Induction versus progression of brain tumour development: differential functions for the Rb and p53 targetting domains of the SV40 T antigen. Mol Cell Biol 14: 2686–2698
Saito M, Helin K, Valentine MB, Griffith BB, Willman CL, Harlow E, Look AT (1995) Amplification of the E2F1 transcription factor gene in the HEL Erythroleukemia cell line. Genomics 25: 130–138
Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA (1995) E2F4 and E2F5, two novel members of the E2F family, are expressed in the early phases of the cell cycle. PNAS 92: 2403–2407
Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang X-F, Nevins JR (1995) Expression of the E2F1 transcription factor overcomes TGFb mediated growth suppression. PNAS 92: 483–487
Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang X-F, Nevins JR (1995) Expression of the E2F1 transcription factor overcomes TGFb mediated growth suppression. PNAS 92: 483–487
Shan B, Lee W-H (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14: 8166–8173
Shan B, Zhu X, Chen P-L, Durfee T, Yang Y, Sharp D, Lee W-H (1992) Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 12: 5620–5631
Singh P, Wong S, Hong W (1994) Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J 13: 3329–3338
Smith EJ, Nevins JR (1995) The Rb related p107 protein can suppress E2F function independently of binding to Cyclin A/cdk2. Mol Cell Biol 15: 338–344
Stein R, Corrigan M, Yaciuk P, Whelan J, Moran E (1990) Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J Virol 64: 4421–4427
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T (1994) p53 dependent apoptosis suppresses tumour growth and progression in vivo. Cell 78: 703–711
Vairo G, Livingston DM, Ginsberg D (1995) Functional Interaction between E2F4 and p130: evidence for distinct mechanisms underlying growth suppression by different Rb family members. Genes Dev 9: 869–881
Weintraub SJ, Prater CA, Dean DC (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358: 259–261
White E, Cipriani R, Sabbatini P, Denton A (1991) Adenovirus El B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol 65: 2968–2978
Wu C-L, Zukerberg LR, Ngwu C, Harlow E, Lees JA (1995) In vivo association of E2F and Dp family proteins. Mol Cell Biol 15: 2536–2546
Wu X, Levine AJ (1994) p53 and E2F1 Cooperate to Mediate Apoptosis. Proc Natl Acad Sci USA 91: 3602–3606
Xu G, Livingston D, Krek W (1995) Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 92: 1357–1361
Xu M, Sheppard KA, Peng C-Y, Yee AS, Piwnica-Worms H (1994) Cyclin A/cdk2 binds directly to E2F1 and inhibits the DNA-binding activity of E2F1/DP1 by phosphorylation. Mol Cell Biol 14: 8420–8431
Yamamoto M, Yoshida M, Ono K, Fujita T, Ohtani-Fujita N, Sakai T, Nikaido T (1994) Effect of tumor suppressors on cell cycle-regulatory genes. Exp Cell Res 210: 94–101
Zamanian M, La Thangue NB (1992) Adenovirus E1A prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J 11: 2603–2610
Zhu L, van der Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111–1125
Zhu L, Enders G, Lees JA, Beijersbergen RL, Bernards R, Harlow E (1995) The pRB related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J 14: 1904–1913
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Adams, P.D., Kaelin, W.G. (1996). The Cellular Effects of E2F Overexpression. In: Farnham, P.J. (eds) Transcriptional Control of Cell Growth. Current Topics in Microbiology and Immunology, vol 208. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79910-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-79910-5_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79912-9
Online ISBN: 978-3-642-79910-5
eBook Packages: Springer Book Archive